Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets

Por Alon, Uri S., Levy-Olomucki, Rachel, Moore, Wayne V., Stubbs, Jason, Liu, Shiguang, Quarles, L. Darryl
Publicado em 2008

New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells

Por Li, Xiaoyu, Kover, Karen L., Heruth, Daniel P., Watkins, Dara J., Moore, Wayne V., Jackson, Kathyrin, Zang, Mengwei, Clements, Mark A., Yan, Yun
Publicado no Mol Endocrinol (2015)

A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency

Por Moore, Wayne V., Nguyen, Huong Jil, Kletter, Gad B., Miller, Bradley S., Rogers, Douglas, Ng, David, Moore, Jerome A., Humphriss, Eric, Cleland, Jeffrey L., Bright, George M.
Publicado no J Clin Endocrinol Metab (2016)

Expression and Regulation of Nampt in Human Islets

Por Kover, Karen, Tong, Pei Ying, Watkins, Dara, Clements, Mark, Stehno-Bittel, Lisa, Novikova, Lesya, Bittel, Doug, Kibiryeva, Nataliya, Stuhlsatz, Jacob, Yan, Yun, Ye, Shui Qing, Moore, Wayne V.
Publicado em 2013

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial

Por Gitelman, Stephen E., Gottlieb, Peter A., Felner, Eric I., Willi, Steven M., Fisher, Lynda K., Moran, Antoinette, Gottschalk, Michael, Moore, Wayne V., Pinckney, Ashley, Keyes-Elstein, Lynette, Harris, Kristina M., Kanaparthi, Sai, Phippard, Deborah, Ding, Linna, Bluestone, Jeffrey A., Ehlers, Mario R.
Publicado no Diabetologia (2016)

Targeting effector memory T cells with alefacept in new onset type 1 diabetes: 12 month results from the T1DAL study

Por Rigby, Mark R, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Patel, Chetanbabu M, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Moran, Antoinette, Russell, William E, Pinckney, Ashley, Keyes-Elstein, Lynette, Howell, Michael, Aggarwal, Sudeepta, Lim, Noha, Phippard, Deborah, Nepom, Gerald T, McNamara, James, Ehlers, Mario R
Publicado em 2013

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

Por Rigby, Mark R., Harris, Kristina M., Pinckney, Ashley, DiMeglio, Linda A., Rendell, Marc S., Felner, Eric I., Dostou, Jean M., Gitelman, Stephen E., Griffin, Kurt J., Tsalikian, Eva, Gottlieb, Peter A., Greenbaum, Carla J., Sherry, Nicole A., Moore, Wayne V., Monzavi, Roshanak, Willi, Steven M., Raskin, Philip, Keyes-Elstein, Lynette, Long, S. Alice, Kanaparthi, Sai, Lim, Noha, Phippard, Deborah, Soppe, Carol L., Fitzgibbon, Margret L., McNamara, James, Nepom, Gerald T., Ehlers, Mario R.
Publicado no J Clin Invest (2015)